Network
The large node is Accord-UK LTD. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 28
- Ajay Varshney 2022-2023 View profile
- Pradeep Prabhudas Bhagia 2021-2023 View profile
- Priscilla Anne Lethbridge 2017-2021 View profile
- James Charles Burt 2017-2021 View profile
- Sandra Lee 2013-2021 View profile
- Lars Peter Ramneborn 2010-2016 View profile
- Richard Simon Hollies 2009-2013 View profile
- Michael James Cann 2009-2014 View profile
- Goran Stojilkovic 2009-2012 View profile
- Paul Anthony Fleming 2005-2007 View profile
- Svend Andersen 2004-2010 View profile
- Sara Jayne Vincent 2004-2017 View profile
- Russell Peter Howard 2002-2004 View profile
- Andrew John Collier 2002-2003 View profile
- Ronald Jeffrey Morrod 2000-2003 View profile
- Ingrid Beichman Wiik 1998-2001 View profile
- Carl Ake Carlsson 1998-2005 View profile
- David John Green 2001 View profile
- Dr William Bogie 1993 View profile
- Dr Peter Robert Read 1998 View profile
- Dr William Mcdowell 1994 View profile
- Michael John Leatham 2001 View profile
- James Elliot Scarth 2006-2008 View profile
- Mark William Warren 2003-2009 View profile
- Brian Mcgovern 2000-2003 View profile
- Michael Joel Blum 1999-2005 View profile
- Peter John Grinstead 1991-2000 View profile
- Edward Roy Wood 1991 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
Public contracts won
16 contracts · £15,529,353 totalFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.
-
NHS National Generic Pharmaceuticals - Wave 16a
NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…
Framework -
SARS-CoV-2 Adult Vaccine Supply (2026)
Contract for the supply of immunisation products indicated for the prevention of, or protection against, SARS-CoV-2 in Adults (2026). A single contract has been awarded for two Lots: Lot 1, Adult SARS-CoV-2 vaccines with a shelf-life of …
-
Anti-Infective Drugs 3
Generic Anti-Infective Drugs
-
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
CM/PHR/20/5591/01 - Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20…
Framework -
Cytokine Modulators
Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a “Lot”. Full deta…
Framework -
Cytokine Modulators
Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a “Lot”. Full deta…
Framework -
NHS National Generic Pharmaceuticals Interim 2 2020
Hospital only products - All regions:01/02/2021 to 31/01/2022Orals (plus non-parenterals) – Allregions: 01/03/2021 to 28/02/202212 months with an option or options toextend (at the Authority’s discretion) fora period or periods up to a tota…
Framework -
Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)Open Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)
The Department of Health and Social Care (DHSC) has awarded multiple contracts for the supply of pharmaceutical products for a UK stockpile of end of life care medicines, intensive care unit (ICU) medicines and antibiotics. The Department o…
-
Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)Open Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)
The Department of Health and Social Care (DHSC) has awarded multiple contracts for the supply of pharmaceutical products for a UK stockpile of end of life care medicines, intensive care unit (ICU) medicines and antibiotics. The Department o…
-
NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a …
Framework -
NP36126 Antibiotic & Genito Urinary Medicines
Supply of Antibiotic & Genito Urinary Medicines to NHS Scotland.
Framework -
NHS National Branded Interim - 1 June 2026
Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months
Framework -
Under-18 SARS-CoV-2 Vaccine Supply (2026)
Contract for the supply of immunisation products indicated for the prevention of, or protection against, SARS-CoV-2 in Under-18s (2026).
-
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion f…
Framework -
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731 Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or per…
Framework -
Generic, Branded Generic & Proprietary Medicinal Products - Group 18
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)
-
Generic Drugs – Injections/Infusions 2
The supply of Generic Drugs – Injections/Infusions 2
About
- Incorporated
- 30/12/1903
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Accord Healthcare Limited
75-100% shares · notified 2017-01-09
Group
- Accord-UK LTD
is controlled by Accord Healthcare Limited
Evidence
active 75-100% shares · notified 2017-01-09 · source: Companies House PSC register
Ultimately controlled by Accord Healthcare Limited.
3 other companies in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
2 directors on the board
- Jonathan Thomas Wilson Director · appointed 2009
- Jamie Sparrow Director · appointed 2023
Directors past 6 years
- Jonathan Thomas Wilson Director · appointed 2009
First-time vs portfolio directors
First-time (2)
- Jonathan Thomas Wilson Director · appointed 2009
- Jamie Sparrow Director · appointed 2023
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 00079585
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data